Targeting liver X receptors in cancer therapeutics

Area of Science:

• Molecular biology
• Endocrinology
• Oncology

Background:

• Nuclear receptors are critical transcription factors with significant therapeutic potential.
• Liver X receptors (LXRs) regulate cholesterol, glucose, and inflammation.
• Growing evidence links LXRs to various cancers.

Purpose of the Study:

• To review the discovery and characterization of LXRs and their ligands.
• To summarize LXR effects and mechanisms in preclinical cancer models.
• To outline future directions for LXR research in cancer therapeutics.

Main Methods:

• Literature review of LXR discovery and characterization.
• Analysis of preclinical cancer models investigating LXR activity.
• Synthesis of current understanding of LXR mechanisms in cancer.

Main Results:

• LXRs are involved in diverse cellular functions beyond their established roles.
• LXR ligands demonstrate therapeutic potential in preclinical cancer studies.
• Specific mechanisms of LXR action in different cancer types are being elucidated.

Conclusions:

• LXRs represent a promising target for cancer therapy.
• Further research is needed to translate preclinical findings into clinical applications.
• Targeting LXRs offers a novel strategy for modulating cancer progression and treatment.